These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 32277807)

  • 1. Total tumour volume as a prognostic factor in patients with resectable colorectal cancer liver metastases.
    Tai K; Komatsu S; Sofue K; Kido M; Tanaka M; Kuramitsu K; Awazu M; Gon H; Tsugawa D; Yanagimoto H; Toyama H; Murakami S; Murakami T; Fukumoto T
    BJS Open; 2020 Jun; 4(3):456-466. PubMed ID: 32277807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal Treatment Strategy of Chemotherapeutic Intervention in Patients with Colorectal Liver Metastases.
    Shimura Y; Komatsu S; Nagatani Y; Funakoshi Y; Sofue K; Kido M; Kuramitsu K; Gon H; Fukushima K; Urade T; So S; Yanagimoto H; Toyama H; Minami H; Fukumoto T
    Ann Surg Oncol; 2023 Oct; 30(11):6603-6610. PubMed ID: 37386304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of total tumor volume in patients with colorectal liver metastases: A secondary analysis of the randomized CAIRO5 trial with external cohort validation.
    Michiel Zeeuw J; Wesdorp NJ; Ali M; Bakker AJJ; Voigt KR; Starmans MPA; Roor J; Kemna R; van Waesberghe JHTM; van den Bergh JE; Nota IMGC; Moos SI; van Dieren S; van Amerongen MJ; Bond MJG; Chapelle T; van Dam RM; Engelbrecht MRW; Gerhards MF; van Gulik TM; Hermans JJ; de Jong KP; Klaase JM; Kok NFM; Leclercq WKG; Liem MSL; van Lienden KP; Quintus Molenaar I; Patijn GA; Rijken AM; Ruers TM; de Wilt JHW; Verpalen IM; Stoker J; Grunhagen DJ; Swijnenburg RJ; Punt CJA; Huiskens J; Verhoef C; Kazemier G
    Eur J Cancer; 2024 Aug; 207():114185. PubMed ID: 38924855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of perihepatic lymph node metastases in patients with resectable colorectal liver metastases.
    Okuno M; Goumard C; Mizuno T; Kopetz S; Omichi K; Tzeng CD; Chun YS; Lee JE; Vauthey JN; Conrad C
    Br J Surg; 2018 Aug; 105(9):1200-1209. PubMed ID: 29664996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Metformin Use on Survival in Patients Undergoing Liver Resection for Colorectal Cancer Metastases.
    Kaltenmeier C; Morocco B; Yazdani H; Reitz K; Meyer K; Molinari M; Geller D; Tohme S
    Am Surg; 2021 Nov; 87(11):1766-1774. PubMed ID: 34766506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection.
    Liu YW; Lu CC; Chang CD; Lee KC; Chen HH; Yeh WS; Hu WH; Tsai KL; Yeh CH; Wee SY; Yin SM; Wang CC; Hung CH
    Sci Rep; 2020 Apr; 10(1):6459. PubMed ID: 32296122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-dimer predicts postoperative recurrence and prognosis in patients with liver metastasis of colorectal cancer.
    Watanabe A; Araki K; Harimoto N; Kubo N; Igarashi T; Ishii N; Yamanaka T; Hagiwara K; Kuwano H; Shirabe K
    Int J Clin Oncol; 2018 Aug; 23(4):689-697. PubMed ID: 29574651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic implications of primary colorectal tumor location on recurrence and overall survival in patients undergoing resection for colorectal liver metastasis.
    Sasaki K; Andreatos N; Margonis GA; He J; Weiss M; Johnston F; Wolfgang C; Antoniou E; Pikoulis E; Pawlik TM
    J Surg Oncol; 2016 Dec; 114(7):803-809. PubMed ID: 27792291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of high ligation on survival of patients undergoing surgery for primary colorectal cancer and synchronous liver metastases.
    Matsui S; Okabayashi K; Hasegawa H; Tsuruta M; Shigeta K; Ishida T; Yamada T; Kondo T; Yamauchi S; Sugihara K; Kitagawa Y
    BJS Open; 2020 Jun; 4(3):508-515. PubMed ID: 32243733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of the C-Reactive Protein/Albumin Ratio and Systemic Immune-Inflammation Index for Patients With Colorectal Liver Metastasis Undergoing Curative Resection.
    Deng Y; Zhao Y; Qin J; Huang X; Wu R; Zhou C; Pan Z
    Pathol Oncol Res; 2021; 27():633480. PubMed ID: 34257601
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic role of infracentimetric colorectal liver metastases.
    Frosio F; Cervantes B; Nassar A; Faermark N; Sanou Y; Bonnet S; Lefevre M; Louvet C; Gayet B; Fuks D
    Langenbecks Arch Surg; 2022 Aug; 407(5):1971-1980. PubMed ID: 35347398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of total tumor volume reduction ratio in initially unresectable colorectal liver metastases after first-line systemic treatment.
    He J; Li W; Zhou J; Sun H; Zhou C; Liu Y; Quan T; Fan W; Pan Z; Lin J; Peng J
    Eur J Radiol; 2023 Aug; 165():110950. PubMed ID: 37437437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Disease-Free Interval Between Resection of Primary Colorectal Malignancy and the Detection of Hepatic Metastases Predicts Disease Recurrence But Not Overall Survival.
    Höppener DJ; Nierop PMH; van Amerongen MJ; Olthof PB; Galjart B; van Gulik TM; de Wilt JHW; Grünhagen DJ; Rahbari NN; Verhoef C
    Ann Surg Oncol; 2019 Sep; 26(9):2812-2820. PubMed ID: 31147988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recurrent colorectal liver metastases: who benefits from a second hepatic resection?].
    Konopke R; Volk A; Gastmeier J; Ehehalt F; Distler M; Saeger HD; Kersting S
    Zentralbl Chir; 2014 Apr; 139(2):226-34. PubMed ID: 23846538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative blood loss independently predicts survival and recurrence after resection of colorectal cancer liver metastasis.
    Jiang W; Fang YJ; Wu XJ; Wang FL; Lu ZH; Zhang RX; Ding PR; Fan WH; Pan ZZ; De-Sen Wan
    PLoS One; 2013; 8(10):e76125. PubMed ID: 24098431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of conversion hepatectomy for initially unresectable colorectal liver metastasis.
    Takamizawa Y; Inoue M; Moritani K; Tsukamoto S; Esaki M; Shimada K; Kanemitsu Y
    Langenbecks Arch Surg; 2022 Nov; 407(7):2893-2903. PubMed ID: 36068379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
    Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM
    Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of primary tumour location in patients undergoing hepatic resection for colorectal liver metastasis.
    Wang K; Xu D; Yan XL; Poston G; Xing BC
    Eur J Surg Oncol; 2018 Jun; 44(6):771-777. PubMed ID: 29580735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.